Assignee
DOMAIN THERAPEUTICS
FR·5 granted patents·5 pending applications·6 citations·filing 2013–2023
Top patents by PatentIndex Score
10 records- 0182US11008323B2Substituted tricyclic 1,4-benzodiazepinone derivatives as allosteric modulators of group II metabotropic glutamate receptorsDOMAIN THERAPEUTICS·Filed 2016·Granted May 18, 2021·5 cites·13 claims
- 0263US9434734B2Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptorsDOMAIN THERAPEUTICS·Filed 2013·Granted Sep 6, 2016·1 cites·15 claims
- 0350US2025320224A1Novel par-2 inhibitorsDOMAIN THERAPEUTICS·Filed 2023·Application pending·0 cites
- 0446US2019152979A1Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group ii metabotropic glutamate receptorsDOMAIN THERAPEUTICS·Filed 2019·Application pending·0 cites
- 0544US2022089609A1Substituted quinazolinone derivatives and their use as positive allosteric modulators of mglur4DOMAIN THERAPEUTICS·Filed 2019·Application pending·0 cites
- 0644US2024066027A1Novel par-2 inhibitorsDOMAIN THERAPEUTICS·Filed 2021·Application pending·0 cites
- 0743US12527779B2Prostaglandin E2 (PGE2) EP4 receptor antagonistsDOMAIN THERAPEUTICS·Filed 2020·Granted Jan 20, 2026·0 cites·26 claims
- 0838US10221179B2Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptorsDOMAIN THERAPEUTICS·Filed 2015·Granted Mar 5, 2019·0 cites·21 claims
- 0938US2022298135A15-heteroaryl-pyridin-2-amine compounds as neuropeptide ff receptor antagonistsDOMAIN THERAPEUTICS·Filed 2020·Application pending·0 cites
- 1031US11472806B2Substituted heterocyclic compounds as allosteric modulators of group II metabotropic glutamate receptorsDOMAIN THERAPEUTICS·Filed 2018·Granted Oct 18, 2022·0 cites·14 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →